52334-79-9 Usage
Uses
Used in Pharmaceutical Research and Development:
3-AMINO-6-METHYLPYRIDIN-2-OL is used as a building block in the synthesis of pharmaceutical drugs due to its ability to form various biologically active molecules. Its unique structure allows for the development of new drug candidates with potential therapeutic applications.
Used in Agrochemicals:
In the agrochemical industry, 3-AMINO-6-METHYLPYRIDIN-2-OL is utilized as a precursor for the synthesis of bioactive compounds that can be used in the development of pesticides, herbicides, and other agricultural chemicals to improve crop yield and protect against pests.
Used in Organic Synthesis:
3-AMINO-6-METHYLPYRIDIN-2-OL is employed as an intermediate in organic synthesis for the production of a wide range of chemical compounds. Its versatile structure enables the synthesis of various organic molecules with different functional groups and properties.
Used in Materials Science:
3-AMINO-6-METHYLPYRIDIN-2-OL is used in the development of materials for electronic devices, such as organic light-emitting diodes (OLEDs). Its unique electronic properties make it a promising candidate for improving the performance and efficiency of these devices.
Used in Organic Light-Emitting Diodes (OLEDs):
In the field of OLED technology, 3-AMINO-6-METHYLPYRIDIN-2-OL is used as a component in the design and synthesis of organic materials that exhibit electroluminescent properties. Its incorporation into OLED devices can enhance their performance, brightness, and energy efficiency.
Check Digit Verification of cas no
The CAS Registry Mumber 52334-79-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,3 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52334-79:
(7*5)+(6*2)+(5*3)+(4*3)+(3*4)+(2*7)+(1*9)=109
109 % 10 = 9
So 52334-79-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O/c1-4-2-3-5(7)6(9)8-4/h2-3H,7H2,1H3,(H,8,9)
52334-79-9Relevant academic research and scientific papers
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief
Gado, Francesca,Di Cesare Mannelli, Lorenzo,Lucarini, Elena,Bertini, Simone,Cappelli, Elena,Digiacomo, Maria,Stevenson, Lesley A.,Macchia, Marco,Tuccinardi, Tiziano,Ghelardini, Carla,Pertwee, Roger G.,Manera, Clementina
, p. 276 - 287 (2018/07/21)
The direct activation of cannabinoid receptors (CBRs) results in several beneficial effects; therefore several CBRs ligands have been synthesized and tested in vitro and in vivo. However, none of them reached an advanced phase of clinical development due
Catalytic Reductions and Tandem Reactions of Nitro Compounds Using in Situ Prepared Nickel Boride Catalyst in Nanocellulose Solution
Prathap, Kaniraj Jeya,Wu, Qiong,Olsson, Richard T.,Dinér, Peter
supporting information, p. 4746 - 4749 (2017/09/23)
A mild and efficient method for the in situ reduction of a wide range of nitroarenes and aliphatic nitrocompounds to amines in excellent yields using nickel chloride/sodium borohydride in a solution of TEMPO-oxidized nanocellulose in water (0.01 wt %) is described. The nanocellulose has a stabilizing effect on the catalyst, which increases the turnover number and enables low loading of nickel catalyst (0.1-0.25 mol % NiCl2). In addition, two tandem protocols were developed in which the in situ formed amines were either Boc-protected to carbamates or further reacted with an epoxide to yield β-amino alcohols in excellent yields.
HETEROCYCLIC DERIVATIVES
-
Page/Page column 17, (2011/02/25)
The present invention relates to heterocyclic derivatives, and more particularly, to novel heterocyclic derivatives useful for the preparation of medicaments for treating diseases related to uric acid.
